Why Attend
The gut microbiota’s importance in human health and disease progression spreads far wider than just gastro-intestinal conditions. The immune, nervous and metabolic systems couple the microbiome with the rest of the body and play a crucial and interlinking role in extra-intestinal diseases including neurological, cancer and metabolic conditions.
For the 5th annual European Microbiome Congress, we’ve shifted the focus from gastro-intestinal to extra-intestinal as we examine the latest pre-clinical and clinical data demonstrating the gut microbiota’s role in some of the world’s most critical and costly diseases in modern society.
Join key opinion leaders from across academia and industry to examine the latest research data. This is your opportunity to find outhow others plan to translate the latest understanding of the gut-microbiome into therapeutic drugs that have the power to treat
cancer, metabolic, neurodegenerative and psychiatric disorders.
Submit your poster
Looking to showcase your recent work to the microbiome community?
Our dedicated poster area is the perfect way to get your research noticed and further involve yourself in the congress. In order to present a poster at the forum you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration).
At the Congress, your presentation will be displayed in a dedicated poster area which can be viewed during the networking break.
Series Highlights
Speakers
Adrien Nivoliez
Aletta Kraneveld
In 2016 Aletta Kraneveld (MSc Pharmacy & pharmacologist) was appointed as full professor Interdisciplinary Translational Pharmacology at the Faculty of Science and the Faculty of Veterinary Medicine of the Utrecht University. She has published >120 papers (H-index: 42). Besides science, she is/has been an active member of several boards of (inter)national scientific and societal organizations (Dutch Society of Pharmacology, EPHAR, IUPHAR, Netherlands Federation of Innovative Drug research; Diversity committee UU; Food Lives-NL).
Kraneveld’s current research interests involve targeting the interaction between innate and adaptive immunity as well as host-microbiome interactions in chronic (inflammatory) diseases with pharmaceutical as well as nutritional interventions. The Kraneveld group is focusing research to in depth study the role of the gut-immune-brain-axis in neurodevelopmental and neurodegenerative disorders. Results will further enhance the knowledge of the interaction of microbiome with the immune and nervous systems in chronic conditions in the gut and CNS. Aletta Kraneveld has set up a program that is a (inter)national neuro-immune platform where academia, patient organisations and industry meet for research on the gut-immune-brain axis as target for medicine and medical food concepts.
Andrew Morgan
Dr Andrew Morgan, DuPont Fellow and Chief Scientist, DuPont Nutrition & Health Over 35 years’ experience in research and development including human health & nutrition, animal nutrition, industrial enzymes and crop science as well as innovation management, business development and corporate venturing including founding member of DuPont Nutrition & Health’s Microbiome Venture
Anna Ettore
Dr. Sabine Hazan
Dr. Sabine Hazan, acclaimed Gastroenterologist and founder of ProgenaBiome, LLC, Ventura Clinical Trials, LLC, and Malibu Specialty Center, is at the forefront of medicine. She recently turned her focus from doing Fecal Microbiota Transplant, also known as FMT to better understand the microbiome. FMT is the process of recolonizing the gut with good flora in hopes to cure specific disease. Spearheading advancement in medicine, this treatment is being explored by Dr. Hazan following the leadership of Dr. Thomas Borody and the late Dr. Sydney Finegold to treat Crohn’s disease, Celiac disease, Alzheimer’s disease, Alopecia areata, Autism, Obesity, Metastatic cancer, and recurrent infection with Clostridium difficile. She is a firm believer in the potential to recolonize your gut back to health recognizing that much work is still left to be done.
Well-prepared for these endeavors, Dr. Hazan was the first woman accepted in to the University of Florida as a Clinical Gastroenterology Fellow, and has continued to be a pioneer in medicine. She has over 22 years of experience in clinical trials and has also been published in numerous medical journals. In the past year, she has served as the series editor for the journal Practical Gastroenterology, for a series on the microbiome. As a trailblazer from the start, she believes in using logic when practicing medicine and tries to think outside the box. “I always remind myself that much like every fingerprint is different, every patient’s symptom is different, and one cannot practice like a robot.”
Ben Mullish
Benno Haarman
Benoit Lavast
Christopher Reyes
Georg Zeller
Grégory Lambert
Grégory Lambert’s career has been split between biotech and pharma as VP of R&D and CSO in companies such as Novagali Pharma (now Santen) and Septodont. His responsibilities have included innovation, CMC, pre-clinical and clinical development in both Europe and North America. Grégory also has experience managing IP, business development and general management. He is an inventor on more than 20 patents, he was involved in the IPO of Novagali Pharma and he has driven the development of several pharmaceutical products from the laboratory through to market authorisation. In 2014, Gregory joined the scientific founders of TargEDys as CEO to setup the business plan and start operations, so far has raised over 10M€ in a mixture of grant and VC funding and begins human clinical trials this year.
Imke Mulder
Isablle de Cremoux
Dr James Kinross
Dr. James Kinross is a consultant colorectal surgeon, at St. Mary’s Hospital London. His clinical interests are in minimally invasive and laparoscopic surgery for the treatment of colorectal cancer. He also has an interest in surgical nutrition and modulation of the gut microbiota by pro and prebiotics for improved operative outcomes. He was trained in Northwest London, and he was an NIHR Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in Colorectal Surgery. He was awarded a Royal College of Surgeons of England training fellowship during his PhD and he was funded by the Academy of Medical Sciences as an early stage lecturer. He is a visiting Professor at the Royal College of Surgeons of Ireland. He is currently funded by Bowel and Cancer research and the Imperial BRC.
James McIlroy
Johan Garrsen
Jos Seegers
Karine Clement
Laura Steenbergen
Morten Isaksen
Nader Yaghoubi
Patrice Garnier
Paul Wilmes
Robert Jan Brummer
Ravi Starlz
Arne Materna Ph.D
Shahram Lavasani
Yolanda Sanz Herranz
Dr. Henrik Bjørn Nielsen
Ravi Starzl
Associate Event Partner
Thought Leadership Partner
Metabolon
Website: http://www.metabolon.com/
Metabolon, Inc. is the world’s leading health technology company advancing metabolomics for clinical and research uses. Its Precision Metabolomics™ is accelerating research and product development across the pharmaceutical, biotechnology, consumer products, and nutrition industries. The company was founded in 2000 and is based in Research Triangle Park, North Carolina.
Event Partners
Clinical Microbiomics
Website: http://www.clinical-microbiomics.com
Clinical Microbiomics is specialized in microbiome metagenomics and innovative bioinformatics concepts. We offer end-to-end microbiome research services for clinical and pre-clinical research including DNA-extraction, library preparation, sequencing and bioinformatics. Our proprietary bioinformatics platform provides our partners with leading capabilities to analyze and interpret microbiome metagenomics data.
With our pioneering Metagenomic Species Concept (MGS) and the most extensive collection of deep-sequenced human and mouse gut samples, we capture up to 80% of the microbiome diversity, which greatly supersedes normal reference-based methods. This provides our clients with a market-leading platform for studying the microbiome in relation to health, disease and treatment interventions. In addition, it allows for diverse applications, such as biomarker and drug target discovery, disease etiology investigation and subject stratification. With our range of advanced bioinformatics tools and experience in big data integration, we are able to move from association studies to mechanistic insights on microbiome metabolism and dynamics.
Biose Industrie
Website: https://www.biose.com/en/cdmo/
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products. Founded in 1951, Biose Industrie has more than 65 years of experience in the development and production of live bacteria based drugs. Company offers lab development specialised in microbiology (anaerobic, aerobic, GMO strains) and is Drug GMP certified for the manufacturing of API (From 300L to 3 500L), clinical batches and commercial drug products (capsules in blisters or pills, sachets).
M2P Labs
Website: http://www.m2p-labs.com/
Based in Baesweiler, Germany (near Aachen), the company was founded in November 2005 as a spin-off of RWTH Aachen University. The company focuses on microreaction and automated solutions for screening and bioprocess development. Our commercialized products are the BioLector, the BioLector Pro, and the FlowerPlate, which provide an intelligent micro fermentation platform. This proprietary technology empowers the biotechnology, chemical, and pharmaceutical industries to increase the number and the information content of microbial experiments (aerobic, microaerophilic, and strictly anaerobic). It enables customers to conduct experiments with high efficiency and excellent quality in microscale at low costs. With the RoboLector, the company also enables the
automated fermentation of the whole bioprocess, with the specific integration of the BioLector tool into a liquid handling system.
Zymo Research
Website: http://www.zymoresearch.com
Zymo Research is historically recognized for its innovation of high quality nucleic acid purification technologies. Under the branding DNA Purification Made Simple™ and RNA Purification Made Simple™, our technologies are pushing the limits of what is possible with nucleic acid isolation. As The Epigenetics Company™, Zymo Research has also received much attention for its rapidly expanding portfolio of epigenetics products and services. It is our objective to develop and provide the most comprehensive set of tools for DNA, RNA, and epigenetic research and analysis available today. Thousands of peer-reviewed scientific publications from researchers around the world feature our technologies. Through innovation, our scientists have made streamlined DNA methylation detection possible, pioneered the micro-elution column for DNA and RNA purification, developed the simplest and the most sophisticated methods for high-quality plasmid DNA purification, and patented the first RNA purification directly from Trizol® without phase separation among many other leading technologies in the industry.
At Zymo Research, we are committed to quality and guarantee that all of our products and service will meet and exceed your expectations. Our products are constantly evaluated by scientists like you to help ensure their reliability and the highest standard of quality.
Symprove
Website: https://www.symprove.com/
Founded in 2002, Symprove Ltd is committed to developing the understanding of the role of the gut microbiome through extensive research and testing. Their unique water-based food supplement called Symprove was launched in 2010 and contains four unique strains of live and active bacteria to support a healthy microbiome within the context of a healthy diet and lifestyle. Several studies have been carried out on Symprove, demonstrating its effective delivery system and looking at how gut function is impacted by the use of multi-strain live bacteria.
For more information, please contact us at: [email protected].
Diversigen
Website: https://diversigen.com/
Diversigen – Your Expert Source of Reliable Microbiome/Metagenomics Services and Insights
Leverage Diversigen’s CLIA/CAP-accredited microbiome profiling/bioinformatics services across the entire clinical research project lifecycle:
- Quality Leadership - Proven expertise, CLIA/CAP accredited
- Experienced - Pre-clinical studies, large clinical trials to single individual analysis
- Consultative/customized study support
- Breadth of services -16S/metagenomics (WGS)/qPCR development
- Flexible, agnostic bio-informatic pipelines/combined bio-statistical analysis
For more information, visit www.diversigen.com
Cosmos ID
Website: http://www.cosmosid.com
CosmosID®, based in Rockville, Maryland, provides solutions unlocking the microbiome. A provider of Next-Generation Sequencing (NGS) Services and Bioinformatics Solutions, CosmosID focuses on microbiome analysis and the rapid identification and characterization of microorganisms for pharmaceutical R&D, molecular diagnostics, public health, food safety, agriculture, and environmental applications.
Services offered by CosmosID’s CLIA certified laboratory cover the entire workflow from study design to sample collection, extraction, library preparation, NGS, data analysis and publication support.
CosmosID’s cloud-based metagenomics application offers user-friendly access to the largest databases for microbial genomics, antimicrobial resistance (AMR) and virulence (VIR) data and has been independently validated to return metagenomic analyses at strain level resolution with industry leading sensitivity and precision.
Media Partners
Rapid Microbiology
Website: https://www.rapidmicrobiology.com/
Rapidmicrobiology.com is a well-established online resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions.
To keep up-to-date with the latest microbiology news get our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.
Become a Sponsor
Kisaco Research provides the much needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at partner@kisacoresearch.com.
The Agenda
We're excited to share that the agenda for the 5th annual European Microbiome Congress is now live. To find out what you can expect onsite, please download the agenda.
NEW FOR 2019:
The gut microbiota has been proven to be a viable drug target for gastro-intestinal diseases such as IBD, Crohns and Colitis - however, there is growing (pre)clinical data to translate findings from the gut microbiome to extra-intestinal conditions. This year, we will explore beyond the gut and focus on 3 major topics:
Gut-brain axis
Microbiome-oncology
Microbiome and metabolic diseases
Download Agenda
Venue
Olympia London, Hammersmith Rd, London W14 8UX
Hilton London Olympia, 380 Kensington High Street, London W14 8NL (0.2miles from the Olympia Conference Centre)
Rate: £215 includes VAT including English breakfast, single occupancy
Book online: http://eventsathilton.com/show/5cacc48e2322ec7c5fd65560
Book by 13th October 2019.
The Copthorne Tara Hotel, Scarsdale Place, London, W8 5SR (1.0mile from Olympia Conference Centre)
Rate per night: £130 includes VAT and breakfast, single occupancy
Call reservations + 44 (0) 207 872 2000
Email:[email protected]
Quote code GA1L121119 when booking
Book by 15th October 2019.
Ibis Earl’s Court Hotel, 47 Lillie Road, Fulham, London, SW6 1UD (1.0mile from the Olympia Conference Centre)
Rate: £99 includes VAT and breakfast, single occupancy
Email: Email Enrico in reservations on [email protected]
Phone: Enrico on +44(0) 207 666 8495
Quote booking code KISACO121119-1 when booking.
Book by 15th October 2019.
Millennium Gloucester Hotel, 4-18 Harrington Gardens, South Kensington, London, SW7 4LH (1.5miles from the Olympia Conference Centre)
Rate per night: £170 includes vat and breakfast, single occupancy
Book online: https://www.millenniumhotels.com/en/london/millennium-gloucester-hotel-london-kensington/
Select dates, click on advanced search and add the code KISA12119 in the promo box.
Call reservations on +44(0) 207 331 6195
Email: reservations.glouce[email protected]
Quote code KISA12119 when booking.
Book by 8th October 2019.
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Ticket prices increase in
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.